Objectives The central nervous system is a significant extraglandular target in primary Sjögren’s syndrome (pSS), often ...
Recent studies highlight the potential of minimal residual disease (MRD) testing to influence treatment decisions in multiple ...
In this installment of Chief Insights in Oncology, John M. Burke, MD, co-editor in chief of Targeted Therapies in Oncology, discusses his column from the September II 2025 issue.
2) The Oral Glucose Tolerance Test (OGTT) evaluates blood sugar levels two hours post-consumption of a 75 g glucose solution.
Accurate measurement of time-varying systematic risk exposures is essential for robust financial risk management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback